4xNFkB Luc Citations (8)
Originally described in: Johannes Schmid plasmidsUnpublished
Articles Citing 4xNFkB Luc
| Articles |
|---|
| Nurr1 Modulation Mediates Neuroprotective Effects of Statins. Willems S, Marschner JA, Kilu W, Faudone G, Busch R, Duensing-Kropp S, Heering J, Merk D. Adv Sci (Weinh). 2022 Jun;9(18):e2104640. doi: 10.1002/advs.202104640. Epub 2022 Apr 30. PubMed |
| Interferon-Inducible E3 Ligase RNF213 Facilitates Host-Protective Linear and K63-Linked Ubiquitylation of Toxoplasma gondii Parasitophorous Vacuoles. Hernandez D, Walsh S, Saavedra Sanchez L, Dickinson MS, Coers J. mBio. 2022 Oct 26;13(5):e0188822. doi: 10.1128/mbio.01888-22. Epub 2022 Sep 26. PubMed |
| Chemogenomics for NR1 nuclear hormone receptors. Isigkeit L, Schallmayer E, Busch R, Brunello L, Menge A, Elson L, Muller S, Knapp S, Stolz A, Marschner JA, Merk D. Nat Commun. 2024 Jun 18;15(1):5201. doi: 10.1038/s41467-024-49493-6. PubMed |
| Live biotherapeutic enterococcus lactis MNC-168 promotes the efficacy of immune checkpoint blockade in cancer therapy by activating STING pathway via bacterial membrane vesicles. Xian Y, Chen Z, Lan Z, Zhang C, Sun H, Liu Z, Kong P, Liang Y, Zhao Y, Liu SM, Zhou Y, Gan L, Li B, Su X, Huang B, Xiao C, Zhu R, Zhao G, Lao C, Lin CS, Zhang D, Jiang X. Gut Microbes. 2025 Dec;17(1):2557978. doi: 10.1080/19490976.2025.2557978. Epub 2025 Sep 12. PubMed |
| MicroRNA 196a contributes to the aggressiveness of esophageal adenocarcinoma through the MYC/TERT/NFkappaB axis. Garcia-Castillo J, Martinez-Caceres CM, Bernabe-Garcia M, Munitiz V, Ruiz de Angulo D, Parrilla P, Ortiz A, Martinez de Haro LF, Cayuela ML. Mol Oncol. 2025 Nov;19(11):3305-3324. doi: 10.1002/1878-0261.70048. Epub 2025 Sep 16. PubMed |
| Distinct immune properties of the N- and C-termini of the immunosuppressive domain of Ebola virus glycoprotein. Iampietro M, Periasamy S, Ilinykh PA, Qiu Y, Liu Y, Nagar A, Gong B, Bukreyev A. mBio. 2025 Nov 12;16(11):e0227825. doi: 10.1128/mbio.02278-25. Epub 2025 Oct 9. PubMed |
| Pyoderma gangrenosum caused by the molecular uncoupling of OTULIN catalytic activity and LUBAC binding. Swaminathan B, Gil HM, Bhattad S, Janardhanan J, Mejia Baltodano G, Mariskanish C, Basaria S, Choi JM, Liu Q, Scheepmaker LM, Mohamed M, Boisson B, Casanova JL, Aksentijevich I, Spaan AN, Markle JG. Nat Immunol. 2026 Aug;27(8):1619-1632. doi: 10.1038/s41590-026-02568-6. Epub 2026 Jun 15. PubMed |
| TRAIL splice variant TRAILshort disrupts T cell receptor signaling and promotes immune tolerance in vivo. Jalali S, Natesampillai S, Nie Z, Zhang Y, Can I, Chandrasekar AP, Hameister BM, Correia C, Zhao TV, Mun DG, Garcia-Rivera E, Matson R, Krogman A, Maynes MA, Batchelor R, Monie DD, Li H, Behfar A, Kenderian SS, Pandey A, Ansell SM, Taner T, Weyand C, Billadeau DD, Badley AD. J Clin Invest. 2026 Aug 3;136(15):e194449. doi: 10.1172/JCI194449. eCollection 2026 Aug 3. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.